Dr. Robert McLafferty was elected president of the Vascular Disease Foundation (VDF) board of directors at their meeting held on March 25th in Chicago, IL. Robert B. McLafferty, MD serves as a Professor in the Division of Vascular Surgery in the Department of Surgery at the Southern Illinois University School of Medicine.

Dr. McLafferty has been a member of VDF’s board of directors since April 2005 and previously served on the Venous Disease Coalition’s steering committee as treasurer. In his new role as president, Dr. McLafferty will continue to lead efforts to increase awareness of vascular disease which affects over 40 million Americans.

“Dr. McLafferty’s commitment and dedication to improving the health care of those affected by vascular disease has been important,” said Sheryl Benjamin VDF executive director. “In his new role as president, he will lead VDF to become the leading resource of vascular disease information. He has a passion to bring vascular disease to the forefront of the national health dialogue. We are honored to have him serve as our new president.”

Dr. McLafferty’s research interests are in the natural history of peripheral arterial and venous diseases; vascular disease treatment outcomes, education, economics, and epidemiology. He has numerous publications in peer reviewed journals and textbooks. He has special interest in the endovascular and surgical treatments of lower extremity occlusive disease, complex aortic aneurysm disease, carotid disease, and venous disease.

About the Vascular Disease Foundation
The Vascular Disease Foundation is a national, nonprofit, public education organization dedicated to increasing awareness of the prevention, diagnosis, and management of vascular disease. Its outstanding board of directors includes physicians, nurses, vascular technologists, rehabilitation professionals, and clinical researchers who have been on the forefront of fighting vascular diseases for many years. For more information, visit http://www.vdf.org or call 888.VDF.4INFO (888.833.4463).

###

Source: Vascular Disease Foundation